Phio Pharmaceuticals

0 followers


Phio Pharmaceuticals develops therapeutics based on ribonucleic acid interference.

Industries

Headquarters

Stage

Employees

Links

Org chart

Robert Bitterman
CEO & Chair

Robert Bitterman

Collapse
Linda Mahoney
SVP of Development
Jim Cardia
VP of Scientific Operations
Caitlin Kontulis
VP, Finance & Administration
Jennifer Phillips
VP, Regulatory & Corporate Affairs